Gut

Papers
(The H4-Index of Gut is 77. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Picking up microbial clues in early-onset colorectal cancer1760
Correction:P97 A patient information bundle outlining dietary advice in liver disease specific to the cost of living crisis improves patient care: ‘Looking after Your Liver for Less’1546
Immunomodulation and entry inhibition: selgantolimod’s double punch against hepatitis B virus1004
Unusual history of ‘stitch’465
Response to McAlindon’s letter341
Innumerable nodules in all parts of the small intestine335
Impact of margin thermal ablation after endoscopic mucosal resection of large (≥20 mm) non-pedunculated colonic polyps on long-term recurrence233
Genetically proxied ketohexokinase function and risk of colorectal cancer: a Mendelian randomisation study221
COVID-19 and liver disease218
Reassessing the prophylactic effect of clip closure to prevent delayed rebleeding after colorectal endoscopic submucosal dissection218
Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches?207
Liquid biopsy to identify Barrett’s oesophagus, dysplasia and oesophageal adenocarcinoma: theEMERALDmulticentre study206
Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis205
Hepatocyte senescence in alcohol-associated hepatitis: epiphenomenon or disease-driving mechanism?196
Perturbation of mRNA splicing in liver cancer: insights, opportunities and challenges189
Where are we with gastric cancer screening in Europe in 2024?186
Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts185
Defining the key intrahepatic gene networks in HCV infection driven by sex180
Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance176
IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells174
Absence of a pancreatic microbiome in intraductal papillary mucinous neoplasm174
Gut virome-colonisingOrthohepadnavirusgenus is associated with ulcerative colitis pathogenesis and induces intestinal inflammationin vivo172
A mucus production programme promotes classical pancreatic ductal adenocarcinoma164
Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre study163
HBcrAg values may predict virological and immunological responses to pegIFN-a in NUC-suppressed HBeAg-negative chronic hepatitis B163
Current therapies and new developments in NASH159
Rate of suitable cases for primary EUS-guided biliary drainage in distal malignant biliary obstruction159
Growth rates and histopathological outcomes of small (6–9 mm) colorectal polyps based on CT colonography surveillance and endoscopic removal150
S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos149
Crohn’s disease and ulcerative colitis exhibit prediagnostic antibody signatures with shared and divergent changes towards disease onset146
Establishment of enterically transmitted hepatitis virus animal models using lipid nanoparticle-based full-length viral genome RNA delivery system144
Finding a mate for MLCK: improving the potential for therapeutic targeting of gut permeability137
Definite benefits of GLP-1 receptor agonists: what is the risk of gastroparesis and lung aspiration?133
Perplexing case of abdominal pain with eosinophilia and fasciitis127
Association between appendectomy and Parkinson’s disease from the UK Biobank124
Correction: Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism120
Selective decontamination of the digestive tract in critically ill children: fighting fire with fire or burning down the house?119
Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studies118
Rare cause of obstructive jaundice117
Tiny contributors to severe obesity inside the gut117
Lumen-apposing metal stents versus double-pigtail plastic stents for infected necrotising pancreatitis: more doubts than answers112
Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression111
Impact of climate change on vulnerable populations111
Intron-mediated enhancement of SPINK1 expression for pancreatitis therapy110
Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model109
Large-scale multiomic analysis identifies non-coding somatic driver mutations and nominates ZFP36L2 as a driver gene for pancreatic ductal adenocarcinoma108
Need for standardised approaches to human microbiome research using the example of colorectal neoplasia research107
Asian Pacific Association of Gastroenterology task force recommendations on surveillance for Helicobacter pylori associated gastric premalignant conditio107
Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma106
New entity of adult ultra-short coeliac disease: the first international cohort and case–control study106
Integrated multimodel analysis of intestinal inflammation exposes key molecular features of preclinical and clinical IBD105
Shaggy white lesion with morphological changes in the oesophagus104
Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance103
24-Nor-ursodeoxycholic acid improves intestinal inflammation by targeting TH17 pathogenicity and transdifferentiation102
Humoral response to SARS-CoV-2 infection among liver transplant recipients102
GI highlights from the literature101
Endoscopic mucosal and submucosal cutting for long benign oesophageal strictures101
Gastrointestinal microbiota and inflammasomes interplay in health and disease: a gut feeling100
Time for arginine methylation: PRMT5 inhibition to advance cholangiocarcinoma treatment100
Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBD95
Unveiling 8 years of duodenoscope contamination: insights from a retrospective analysis in a large tertiary care hospital94
Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression93
MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression92
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer91
Most excess years of potential life loss among individuals with cirrhosis during the pandemic were not related to COVID-1989
Decoding HBV-specific adaptive immunity: from natural clearance to cure89
Endoscopic stratification of gastric intestinal metaplasia: where are we, where do we want to go and how do we get there?88
British Society of Gastroenterology guidelines on sedation in gastrointestinal endoscopy88
SARS-CoV-2 vaccination in patients with GI and hepatobiliary carcinoma: a call for booster vaccination87
Treatment of type 2 diabetes with MASLD: new evidence for personalised medicine85
Environmental and healthcare trade-offs between single-use and reusable gastroscopes84
Reply: Prevalence of serum HBsAg <100 IU/mL in inactive chronic hepatitis B82
A20-mediated KEAP1 ubiquitination orchestrates hepatocyte ferroptosis to ameliorate autoimmune hepatitis81
SMYD2-mediated methylation of STAT1 protects against hepatic ischaemia/reperfusion injury by blocking JAK-STAT1 signalling pathways81
Ebastine for the treatment of irritable bowel syndrome: old drug, new tricks?77
GI highlights from the literature77
Association between inflammatory bowel disease and Alzheimer’s disease: multivariable and bidirectional Mendelian randomisation analyses77
0.1143798828125